• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Oizumi Corporation - Product Image

Oizumi Corporation

  • ID: 635825
  • February 2015
  • 54 Pages
  • Wright Investors Service

A textual analysis of the financial results for Oizumi Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Oizumi Corporation. There is a textual review of the financial results of Oizumi Corporation versus Nippon Dry-Chemical Co., Ltd., Mars Engineering Corporation and Artnature Incorporated. The comparative analysis of these companies compares Sales (sales, sales READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

Micron Machinery Co Ltd, Cota Company Limited and Mamiya-OP Co., Ltd.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Nitin Fire Protection Industries Limited - Product Thumbnail Image

    Nitin Fire Protection Industries Limited

    • Language: English
    • 54 Pages
    • Published: January 2015
    FROM
  • Microsoft Corporation - Product Thumbnail Image

    Microsoft Corporation

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Cota Company Limited - Product Thumbnail Image

    Cota Company Limited

    • Language: English
    • 55 Pages
    • Published: February 2015
  • Mars Engineering Corporation - Product Thumbnail Image

    Mars Engineering Corporation

    • Language: English
    • 54 Pages
    • Published: January 2015
  • Fujishoji Co.Ltd - Product Thumbnail Image

    Fujishoji Co.Ltd

    • Language: English
    • 54 Pages
    • Published: January 2015
  • Mamiya-OP Co., Ltd. - Product Thumbnail Image

    Mamiya-OP Co., Ltd.

    • Language: English
    • 55 Pages
    • Published: January 2015
  • Hexagon Holdings Berhad - Product Thumbnail Image

    Hexagon Holdings Berhad

    • Language: English
    • 40 Pages
    • Published: April 2014
  • Bon Fame Co Limited - Product Thumbnail Image

    Bon Fame Co Limited

    • Language: English
    • 54 Pages
    • Published: January 2015
  • Artnature Incorporated - Product Thumbnail Image

    Artnature Incorporated

    • Language: English
    • 54 Pages
    • Published: February 2015
    FROM
  • Oizumi Acquisition Manual - Product Thumbnail Image Oizumi Acquisition Manual

    Oizumi Acquisition Manual

    • Language: English
    • Published: March 2015

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.